Validation of Accexible as a Tool for Screening and Monitoring Depression.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

178 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-22

Study Completion Date

2025-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

NCT02330679

Major Depressive Disorder

UNKNOWN PHASE4

Using Neuroimaging to Investigate Major Depressive Disorder

NCT00781677

Major Depressive Disorder Depression Anxiety

COMPLETED

Multimodal Identification of Depressive Symptoms in the Elderly

NCT07112118

Depression

NOT_YET_RECRUITING

Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure

NCT02658682

Major Depression

COMPLETED NA

Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale

NCT03872492

Depressive Disorder, Major

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder (MDD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy

Accexible

Intervention Type DEVICE

Speech Analysis

Depression

Accexible

Intervention Type DEVICE

Speech Analysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Accexible

Speech Analysis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult 18-65 years of age.
* Participants must have Spanish as their first language (able to speak and understand verbal messages).
* Participants must have mobile phone with internet.
* Participants must have the ability to understand AcceXible's basic instructions.
* Participants must agree to participate in the study and have voluntarily signed the informed consent.

Exclusion Criteria

* To have received a diagnosis of neurodegeneration.
* To have significant vision problems that would affect the ability to perceive visual stimuli.
* To have significant hearing problems that would affect the ability to understand verbal cues.
* To be unable to give informed consent to participate in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes